Total Other — Total revenues
Gilead Sciences Total Other — Total revenues decreased by 3.9% to $196.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.2%, from $209.00M to $196.00M. Over 3 years (FY 2022 to FY 2025), Total Other — Total revenues shows a downward trend with a -5.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful monetization of niche assets or legacy products, while a decrease may indicate the sunsetting of older therapies or a strategic shift away from non-core areas.
Detailed definition
This metric represents the aggregate revenue generated from secondary product lines or miscellaneous therapeutic offerin...
Peer comparison
Peers often report this as 'Other Product Sales' or 'Miscellaneous Revenue,' and it is typically expected to be a small, stable, or declining portion of total revenue compared to primary blockbuster franchises.
gild_segment_total_other_total_revenuesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $236.50M | $236.50M | $236.50M | $236.50M | $214.75M | $214.75M | $214.75M | $214.75M | $224.00M | $280.00M | $201.00M | $184.00M | $209.00M | $202.00M | $184.00M | $204.00M | $196.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -9.2% | +0.0% | +0.0% | +0.0% | +4.3% | +25.0% | -28.2% | -8.5% | +13.6% | -3.3% | -8.9% | +10.9% | -3.9% |
| YoY Change | — | — | — | — | -9.2% | -9.2% | -9.2% | -9.2% | +4.3% | +30.4% | -6.4% | -14.3% | -6.7% | -27.9% | -8.5% | +10.9% | -6.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's total other — total revenues?
- Gilead Sciences (GILD) reported total other — total revenues of $196.00M in Q1 2026.
- How has Gilead Sciences's total other — total revenues changed year-over-year?
- Gilead Sciences's total other — total revenues decreased by 6.2% year-over-year, from $209.00M to $196.00M.
- What is the long-term trend for Gilead Sciences's total other — total revenues?
- Over 3 years (2022 to 2025), Gilead Sciences's total other — total revenues has grown at a -5.5% compound annual growth rate (CAGR), from $946.00M to $799.00M.
- What does total other — total revenues mean?
- The total revenue earned from secondary or miscellaneous products that are not part of the company's primary business segments.